Insights from global data for use of rotavirus vaccines in India

T. S. Rao; Rashmi Arora; Ajay Khera; Jacqueline E. Tate; Umesh Parashar; Gagandeep Kang; M. K. Bhan; Ashish Bavdekar; Temsunaro R. Chandola; Nita Bhandari; Sunita Taneja; Tivendra Kumar; Vinohar Balraj; Jayaprakash Muliyil; Jacob John; Mohan V. Raghava; Rajiv Sarkar; Umesh D. Parashar; Nicholas C. Grassly; Mathuram Santosham

doi:10.1016/j.vaccine.2014.03.029

Insights from global data for use of rotavirus vaccines in India

T. S. Rao, Rashmi Arora, Ajay Khera, Jacqueline E. Tate, Umesh Parashar, Gagandeep Kang, M. K. Bhan, Ashish Bavdekar, Temsunaro R. Chandola, Nita Bhandari, Sunita Taneja, Tivendra Kumar, Vinohar Balraj, Jayaprakash Muliyil, Jacob John, Mohan V. Raghava, Rajiv Sarkar, Umesh D. Parashar, Nicholas C. Grassly, Mathuram Santosham

Bloomberg School of Public Health

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Rotavirus vaccines are being introduced in several low- and middle-income countries across the world with and without support from the GAVI Alliance. India has the highest disease burden of rotavirus based on morbidity and mortality estimates and several indigenous vaccine manufacturers are developing rotavirus vaccines. One candidate has undergone phase III testing and others have completed evaluation in phase II. Global data on licensed vaccine performance in terms of impact on disease, strain diversity, safety and cost-effectiveness has been reviewed to provide a framework for decision making in India.

Original language	English (US)
Pages (from-to)	A171-A178
Journal	Vaccine
Volume	32
Issue number	S1
DOIs	https://doi.org/10.1016/j.vaccine.2014.03.029
State	Published - 2014

ASJC Scopus subject areas

Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2014.03.029

Cite this

Rao, T. S., Arora, R., Khera, A., Tate, J. E., Parashar, U., Kang, G., Bhan, M. K., Bavdekar, A., Chandola, T. R., Bhandari, N., Taneja, S., Kumar, T., Balraj, V., Muliyil, J., John, J., Raghava, M. V., Sarkar, R., Parashar, U. D., Grassly, N. C., & Santosham, M. (2014). Insights from global data for use of rotavirus vaccines in India. Vaccine, 32(S1), A171-A178. https://doi.org/10.1016/j.vaccine.2014.03.029

Rao, TS, Arora, R, Khera, A, Tate, JE, Parashar, U, Kang, G, Bhan, MK, Bavdekar, A, Chandola, TR, Bhandari, N, Taneja, S, Kumar, T, Balraj, V, Muliyil, J, John, J, Raghava, MV, Sarkar, R, Parashar, UD, Grassly, NC & Santosham, M 2014, 'Insights from global data for use of rotavirus vaccines in India', Vaccine, vol. 32, no. S1, pp. A171-A178. https://doi.org/10.1016/j.vaccine.2014.03.029

@article{4e96469e96e44fa28acf539ac03054bb,

title = "Insights from global data for use of rotavirus vaccines in India",

abstract = "Rotavirus vaccines are being introduced in several low- and middle-income countries across the world with and without support from the GAVI Alliance. India has the highest disease burden of rotavirus based on morbidity and mortality estimates and several indigenous vaccine manufacturers are developing rotavirus vaccines. One candidate has undergone phase III testing and others have completed evaluation in phase II. Global data on licensed vaccine performance in terms of impact on disease, strain diversity, safety and cost-effectiveness has been reviewed to provide a framework for decision making in India.",

author = "Rao, {T. S.} and Rashmi Arora and Ajay Khera and Tate, {Jacqueline E.} and Umesh Parashar and Gagandeep Kang and Bhan, {M. K.} and Ashish Bavdekar and Chandola, {Temsunaro R.} and Nita Bhandari and Sunita Taneja and Tivendra Kumar and Vinohar Balraj and Jayaprakash Muliyil and Jacob John and Raghava, {Mohan V.} and Rajiv Sarkar and Parashar, {Umesh D.} and Grassly, {Nicholas C.} and Mathuram Santosham",

year = "2014",

doi = "10.1016/j.vaccine.2014.03.029",

language = "English (US)",

volume = "32",

pages = "A171--A178",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "S1",

}

TY - JOUR

T1 - Insights from global data for use of rotavirus vaccines in India

AU - Rao, T. S.

AU - Arora, Rashmi

AU - Khera, Ajay

AU - Tate, Jacqueline E.

AU - Parashar, Umesh

AU - Kang, Gagandeep

AU - Bhan, M. K.

AU - Bavdekar, Ashish

AU - Chandola, Temsunaro R.

AU - Bhandari, Nita

AU - Taneja, Sunita

AU - Kumar, Tivendra

AU - Balraj, Vinohar

AU - Muliyil, Jayaprakash

AU - John, Jacob

AU - Raghava, Mohan V.

AU - Sarkar, Rajiv

AU - Parashar, Umesh D.

AU - Grassly, Nicholas C.

AU - Santosham, Mathuram

PY - 2014

Y1 - 2014

N2 - Rotavirus vaccines are being introduced in several low- and middle-income countries across the world with and without support from the GAVI Alliance. India has the highest disease burden of rotavirus based on morbidity and mortality estimates and several indigenous vaccine manufacturers are developing rotavirus vaccines. One candidate has undergone phase III testing and others have completed evaluation in phase II. Global data on licensed vaccine performance in terms of impact on disease, strain diversity, safety and cost-effectiveness has been reviewed to provide a framework for decision making in India.

AB - Rotavirus vaccines are being introduced in several low- and middle-income countries across the world with and without support from the GAVI Alliance. India has the highest disease burden of rotavirus based on morbidity and mortality estimates and several indigenous vaccine manufacturers are developing rotavirus vaccines. One candidate has undergone phase III testing and others have completed evaluation in phase II. Global data on licensed vaccine performance in terms of impact on disease, strain diversity, safety and cost-effectiveness has been reviewed to provide a framework for decision making in India.

UR - http://www.scopus.com/inward/record.url?scp=84905171905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905171905&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2014.03.029

DO - 10.1016/j.vaccine.2014.03.029

M3 - Review article

C2 - 25091672

AN - SCOPUS:84905171905

SN - 0264-410X

VL - 32

SP - A171-A178

JO - Vaccine

JF - Vaccine

IS - S1

ER -

Insights from global data for use of rotavirus vaccines in India

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this